摘要
化疗在乳腺癌综合治疗中有重要地位，目前化疗引起的不良反应已受到临床医生广泛关注，但对其导致的脂肪性肝病及乙肝病毒（hepatitisBvirus，HBV）再激活仍不够重视，将影响部分患者的疗效及预后。本文将对其防治进行探讨。
Chemotherapy plays an important role in the comprehensive treatment of breast cancer, and chemotherapy related fatty liver disease （CRFLD） and hepatitis B virus （HBV） reactivation were still ignored at present. It would cause great influence on the patient＇s outcome. Preventive measures on them will be discussed in this paper.
出处
《中华内分泌外科杂志》
CAS
2017年第5期426-429,共4页
Chinese Journal of Endocrine Surgery
基金
国家自然科学基金（81372851）
关键词
乳腺癌
化疗性脂肪肝
乙肝病毒再激活
Breast cancer
Chemotherapy related fatty liver disease
Hepatitis B virus reactivation
